Kamila Wojas-Krawczyk

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Tyrosine Kinase

Mesenchymal Stem Cells

Small Cell Lung Cancer

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ewa Anna Kalinka, Kamila Wojas-Krawczyk, Paweł Krawczyk
Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients. Cancers 15 (13) (2023)
Natalia Krzyżanowska, Kamila Wojas-Krawczyk, Janusz Milanowski, Paweł Krawczyk
Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules? International journal of molecular sciences 23 (6) (2022)
Natalia Krzyżanowska, Paweł Krawczyk, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Janusz Milanowski
Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy? Cells 11 (20) (2022)
Magdalena Knetki-Wroblewska, Kamila Wojas-Krawczyk, Dariusz Mirosław Kowalski, Maciej Krzakowski
Non-Small-Cell Lung Cancer Patients with Coexistence of High PD-L1 Expression and RET Fusion-Which Path Should We Follow? Case Reports and Literature Review. Journal of clinical medicine 11 (6) (2022)
Michał Szczyrek, Radosław Mlak, Aneta Szudy-Szczyrek, Kamila Wojas-Krawczyk, Karolina Kędziora, Janusz Milanowski
Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer. Cells 11 (6) (2022)
Aleksandra Bożyk, Kamila Wojas-Krawczyk, Paweł Krawczyk, Janusz Milanowski
Tumor Microenvironment-A Short Review of Cellular and Interaction Diversity. Biology 11 (6) (2022)
Paweł Krawczyk, Jacek Jassem, Kamila Wojas-Krawczyk, Maciej Krzakowski, Rafał Dziadziuszko, Włodzimierz Olszewski
New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary. Cancers 14 (14) (2022)
Irena Wieleba, Kamila Wojas-Krawczyk, Paweł Krawczyk, Janusz Milanowski
Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures. International journal of molecular sciences 23 (4) (2022)
Kamila Wojas-Krawczyk, Iwona Paśnik, Tomasz Kucharczyk, Irena Wieleba, Natalia Krzyżanowska, Michał Gil, Paweł Krawczyk, Janusz Milanowski
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy. International journal of molecular sciences 22 (17) (2021)
Kamila Wojas-Krawczyk, Paweł Krawczyk, Michał Gil, Maciej Strzemski
Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients-Mechanism of Action and Future Concepts. Cancers 13 (11) (2021)
Paweł Krawczyk, Anna Grenda, Paulina Terlecka, Justyna Błach, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Izabela Chmielewska, Robert Kieszko, Bożena Jarosz, Michał Gil, Katarzyna Reszka, Janusz Milanowski
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement. Scientific reports 11 (1) (2021)
Justyna Błach, Kamila Wojas-Krawczyk, Marcin Nicoś, Paweł Krawczyk
Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer. International journal of molecular sciences 22 (16) (2021)